Treatment of dermatologic lesions using immunosuppressive agents and cytostatics
Schuppli, R.
Münchener Medizinische Wochenschrift 112(12): 526-530
1970
ISSN/ISBN: 0341-3098 PMID: 5467837 Document Number: 20854
Document emailed within 1 workday
Related Documents
Mitrou, P.S.; Fischer, M.; Mitrou, G. 1976: Oncogenesis due to immunosuppressive agents (cytostatics) in (NZBxNZW) mice Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1729-1731Lagrue, G.; Bariéty, J. 1970: Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents) Münchener Medizinische Wochenschrift 112(12): 515-522
van der Nat, J.M.; Beijnen, J.H.; Driebergen, R.J.; Thart, L.A.; van Dijk, H.; Underberg, W.J.; Labadie, R.P. 1988: In vitro immunosuppressive activities of recently developed anthracycline cytostatics Anticancer Research 8(3): 489-493
Scherf, H.R.; Krüger, C.; Karsten, C. 1970: Studies in rats on immunosuppressive properties of cytostatics with special consideration of carcinogenic effect Arzneimittel-Forschung 20(10): 1467-1470
Frei, P.C. 1973: Treatment of polyarthritis by immunosuppressive agents Schweizerische Medizinische Wochenschrift 103(33): 1159-1161
Borberg, H.; Kindler, J.; Mahieu, B.; Sladecek, I.; Tschöpe, W.; Sieberth, H.G.; Gross, R. 1978: Treatment of the Goodpasture syndrome. Successful combination of plasma exchange and treatment with immunosuppressive agents Die Medizinische Welt 29(13): 545-547
Kamińska, M.; Piotrowicz, E.; Ratajczak, B.; Boj, E. 1973: Treatment of idiopathic pulmonary hemosiderosis with immunosuppressive agents Pediatria Polska 48(6): 765-769
Skłodowski, P. 1993: Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents Neurologia i Neurochirurgia Polska 27(6): 877-883
Carreira Delgado, P.E.; Gómez-Reino Carnota, J.J.; Morillas López, L.; Ibero Díaz, I.; Mateo Bernardo, I. 1986: Effectiveness and safety of immunosuppressive agents in the treatment of rheumatoid arthritis Medicina Clinica 86(14): 575-578
Vignon, G.; Bied, J.C. 1971: Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases Revue du Rhumatisme et des Maladies Osteo-Articulaires 38(12): 785-795
Viozzi, A.; Gasparini, G.; Cagliari, P. 1970: Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization Minerva Ginecologica 22(9): 462-463
Couchoud, C.; Laville, M.; Boissel, J.P. 1994: Treatment of extra-membranous glomerulonephritis with immunosuppressive agents or difficulties of meta-analysis in nephrology Therapie 49(3): 171-173
Slavin, S. 1993: Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT Bone Marrow Transplantation 12(1): 85-88
Schmitt, E.; Kröger, E.; Lakner, V.; Klinkmann, H.; Ratner, M.; Tomilina, N. 1979: Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(17): 465-471
Doss, N.; Haouala, H.; Mhenni, H.; Dhaoui, M.R.; Gueddiche, M. 1991: The dermatologic lesions of the postphlebitic syndrome La Tunisie Medicale 69(2): 79-81
Horvath, P.N. 1982: Dermatologic management of facial lesions Otolaryngologic Clinics of North America 15(1): 49-54
Berton, F.; Veys, A.; Scheiff, J.M.; Hulhoven, R.; de Wil, P. 1983: Sézary syndrome with minimal dermatologic lesions Acta Clinica Belgica 38(6): 369-375
George, J.; Hentzschel, S.; Hünerbein, B.; König, S.; Schäfer, W. 1986: The use of microcrystalline cellulose dispersions for the production of dermatologic agents Die Pharmazie 41(8): 588-590
Schaich, B.; Korting, H.C. 1992: The effect of cosmetics and dermatologic agents on skin lipids Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(7): 403-408
Mertens, H.G. 1980: Immunosuppressive agents Die Medizinische Welt 31(40): 1440-1443